Halma, the leading safety, health and environmental technology group, announces the acquisition of FluxData Incorporated ("FluxData") from private shareholders. FluxData, based in New York State, USA, designs and manufactures advanced multispectral and digital imaging systems across multiple sectors including industrial and medical applications. The cash consideration is $12.0 million (£9.8 million) and is adjustable, US$ [...]

Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif. – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput and efficiency of [...]

High Throughput Sequencing Instruments Capable of Transforming Genomics to Improve Human Health at an Unprecedented Scale Illumina NovaSeq 6000 System SAN DIEGO--Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, today introduced the NovaSeqTM Series, a new and scalable sequencing architecture expected one day to enable a $100 genome. Unveiled at the J.P. [...]

CROMWELL, Conn. & WINDSOR, Conn.--Biological Industries USA, Inc. (BI‐USA) and Rainbow Scientific, Inc. announced today a co‐promotion and sales agreement that grants Rainbow Scientific both promotion and sales rights to BI-USA’s range of cytogenetic products to the clinical laboratory market. “Rainbow Scientific has been a leading distributor to hospital laboratories, medical reference laboratories, and clinical [...]

Newark, Delaware B&W Tek, a mobile spectroscopy solutions company that delivers lab quality Raman, LIBS, UV-Vis and NIR solutions through user-friendly mobile platforms, is excited to announce updates to their intuitive BWID® and BWIQ® software. BWIQ Version 3.0.6 BWIQ is a multivariate analysis software package for the analysis of spectral data, including exploratory and qualitative [...]

Business to be conducted through new wholly owned subsidiary Croptimal TORONTO, ONTARIO--Eurocontrol Technics Group Inc. (TSX VENTURE:EUO)(OTCQB:EUCTF) ("Eurocontrol" or the "Company"), a Canadian public company specializing in the acquisition, development and commercialization of innovative test and measurement technologies for the authentication, verification and certification markets, is pleased to announce that its wholly owned subsidiary Xenemetrix [...]

Structural Variant Detection, De Novo Assembly and Targeted Sequencing Applications Improved MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system's ability to support important applications such as structural variant detection and targeted sequencing— including [...]

SAN DIEGO & HERCULES, Calif.-- Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. [...]

Data interpretation from Watson will help users translate genomic data  from  Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO - IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to  expand access to genome data interpretation by integrating Watson for Genomics into  Illumina’s BaseSpace Sequence Hub and tumor sequencing [...]

Collaboration aims to leverage Illumina’s  world-class DNA sequencing technology and BaseSpace Sequence Hub with Philips’ innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research Amsterdam, the Netherlands, and  San Diego, US - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA [...]